Search research articles
Contact Us
Filters
Showing results (1-10 of 94) with videos related to
Page
of 10
Sort By:
Current Pharmaceutical Biotechnology
|
February 10, 2009
Novel targets in cancer therapy
Debabrata Banerjee
Idrugs : the Investigational Drugs Journal
|
July 4, 2003
EORTC-PAMM Group--24th Winter Meeting. 5-8 February 2003, Florence, Italy
Debabrata Banerjee
Cancers
|
June 1, 2019
Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment
Deepshikha Mishra, Debabrata Banerjee
Current Pharmaceutical Biotechnology
|
February 10, 2009
Tumor initiating cells
Nitu Bansal, Debabrata Banerjee
Cells
|
February 25, 2023
Secretome of Stromal Cancer-Associated Fibroblasts (CAFs): Relevance in Cancer
Deepshikha Mishra, Debabrata Banerjee
Breast Cancer : Basic and Clinical Research
|
September 30, 2015
Subverting Subversion: A Review on the Breast Cancer Microenvironment and Therapeutic Opportunities
Ethan Rothschild, Debabrata Banerjee
Cancers
|
April 15, 2020
Correction: Mishra, et al.; Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment. <i>Cancers</i> 2019, <i>11</i>, 750
Deepshikha Mishra, Debabrata Banerjee
Advances in Experimental Medicine and Biology
|
December 10, 2021
Metabolic Interactions Between Tumor and Stromal Cells in the Tumor Microenvironment
Deepshikha Mishra, Debabrata Banerjee
Expert Review of Anticancer Therapy
|
March 22, 2003
Fluoropyrimidine resistance in colon cancer
Richard Gorlick, Debabrata Banerjee
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2003
Is the measurement of thymidylate synthase to determine suitability for treatment with 5-fluoropyrimidines ready for prime time?
Joseph R Bertino, Debabrata Banerjee
Page
of 10
Search research articles
Search
Showing results (1-10 of 94) with videos related to
Sort By:
Page
of 10
Current Pharmaceutical Biotechnology
|
February 10, 2009
Novel targets in cancer therapy
Debabrata Banerjee
Idrugs : the Investigational Drugs Journal
|
July 4, 2003
EORTC-PAMM Group--24th Winter Meeting. 5-8 February 2003, Florence, Italy
Debabrata Banerjee
Cancers
|
June 1, 2019
Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment
Deepshikha Mishra, Debabrata Banerjee
Current Pharmaceutical Biotechnology
|
February 10, 2009
Tumor initiating cells
Nitu Bansal, Debabrata Banerjee
Cells
|
February 25, 2023
Secretome of Stromal Cancer-Associated Fibroblasts (CAFs): Relevance in Cancer
Deepshikha Mishra, Debabrata Banerjee
Breast Cancer : Basic and Clinical Research
|
September 30, 2015
Subverting Subversion: A Review on the Breast Cancer Microenvironment and Therapeutic Opportunities
Ethan Rothschild, Debabrata Banerjee
Cancers
|
April 15, 2020
Correction: Mishra, et al.; Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment. <i>Cancers</i> 2019, <i>11</i>, 750
Deepshikha Mishra, Debabrata Banerjee
Advances in Experimental Medicine and Biology
|
December 10, 2021
Metabolic Interactions Between Tumor and Stromal Cells in the Tumor Microenvironment
Deepshikha Mishra, Debabrata Banerjee
Expert Review of Anticancer Therapy
|
March 22, 2003
Fluoropyrimidine resistance in colon cancer
Richard Gorlick, Debabrata Banerjee
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2003
Is the measurement of thymidylate synthase to determine suitability for treatment with 5-fluoropyrimidines ready for prime time?
Joseph R Bertino, Debabrata Banerjee
Page
of 10